Related Experiment Video
Updated: Mar 6, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p21: A Two-Faced Genome Guardian
Alexandros G Georgakilas1, Olga A Martin2, William M Bonner3
1DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Iroon Polytechniou 9, Zografou 15780, Athens, Greece.
Abstract:
Upon DNA damage or other stressors, the tumor suppressor p53 is activated, leading to transient expression of the cyclin-dependent kinase inhibitor (CKI) p21. This either triggers momentary G1 cell cycle arrest or leads to a chronic state of senescence or apoptosis, a form of genome guardianship. In the clinic, the presence of p21 has been considered an indicator of wildtype p53 activity. However, recent evidence suggests that p21 also acts as an oncogenic factor in a p53-deficient environment. Here, we discuss the controversial aspects of the two-faced involvement of p21 in cancer and speculate on how this new information may increase our understanding of its role in cancer pathogenesis. Prevailing notions indicate that p21 might also act as antiapoptotic agent, which may have relevant implications for future therapeutic strategies.
Insights
The tumor suppressor p21, typically a guardian of the genome, can also promote cancer in a p53-deficient environment. This dual role has significant implications for cancer therapy and understanding disease progression.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Cycle Regulation
Background:
- The tumor suppressor p53 is activated by DNA damage, inducing p21 expression.
- p21 (cyclin-dependent kinase inhibitor) typically causes cell cycle arrest, senescence, or apoptosis.
- p21 presence is often a marker for wildtype p53 activity in clinical settings.
Purpose of the Study:
- To discuss the dual role of p21 in cancer.
- To explore the oncogenic functions of p21 in p53-deficient cancers.
- To consider the implications of p21's multifaceted role in cancer pathogenesis and therapy.
Main Methods:
- Literature review and discussion of existing evidence.
- Analysis of the contrasting roles of p21 in different cellular contexts.
- Speculative analysis based on current research findings.
Main Results:
- p21 acts as a tumor suppressor in a p53-wildtype context.
- p21 can function as an oncogene in p53-deficient tumors.
- p21 may also possess anti-apoptotic functions, complicating its role.
Conclusions:
- The role of p21 in cancer is context-dependent and paradoxical.
- Understanding p21's dual function is crucial for developing effective cancer therapies.
- p21's potential anti-apoptotic activity requires further investigation for therapeutic targeting.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
10:10HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
DNA Microarrays
Genomic DNA in Eukaryotes
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...